Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07703436 |
| Title | Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive Disease |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | Nuvation Bio Inc. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of California, Los Angeles | Los Angeles | California | 90095 | United States | Details | |
| University of California, San Francisco | San Francisco | California | 94143 | United States | Details | |
| Rutgers Cancer Institute | New Brunswick | New Jersey | 08901 | United States | Details | |
| NYU Langone Health | New York | New York | 10016 | United States | Details | |
| University of Rochester Medical Center | Rochester | New York | 14642 | United States | Details |